Login

Categories

Consumer Corporate Energy Entertainment Experts Financials Healthcare Industrial Law Markets Media Mining Private Equity Real Estates Sports Startups Technology Venture Capital

Recent Videos

00:00:00
Introducing Silence Therapeutics - Mark Rothera, President and CEO of Silence Therapeutics
00:00:00
SkinBio Therapeutics (SBTX) is a life science company - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:00:00
SkinBioTherapeutics (SBTX) - Stuart Ashman, CEO
00:00:00
SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities" - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:00:00
Skinbiotherapeutics get set for live data trial to target skin conditions including psoriasis - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:00:00
Mike Timoney: Introduction to Smiles Inclusive - a new model for dental partnerships - Mike Timiney, CEO, Smiles Inclusive Ltd
00:00:00
Smiles Inclusive (ASX:SIL): Mike Timoney, Chief Executive Officer
00:00:00
Soligenix; An Introduction to Christopher J. Schaber - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Soligenix, Inc.'s interview with Dr. Christopher J. Schaber, Chairman, President, and CEO - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
"Treating Rare Diseases" – Soligenix, Inc.'s interview - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Soligenix Inc is a late-stage biopharmaceutical company - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Soligenix CEO Chris Schaber highlights the company's major milestones - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Chris Schaber, Soligenix Inc., talks about the collaborative efforts of the industry in response to COVID-19 - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Soligenix (NASDAQ: SNGX) is developing and commercializing products to treat rare diseases - Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
Christopher J. Schaber, PhD Chairman, President and Chief Executive Officer, Soligenix Inc
00:00:00
CEO Erik Kinnman presents Sprint Bioscience - Erik Kinnman, CEO, Sprint Bioscience
00:00:00
CEO Andrew Morris explains why SQI’s recently-announced product development agreement - Andrew Morris DIRECTOR AND CHIEF EXECUTIVE OFFICER, SQI Diagnostics Inc
00:10:00
Shapiro Administration & CNX Resources Forge Environmental Monitoring Partnership | Nicholas J. DeIuliis- CEO of CNX Resources
00:10:00
COAL of Africa CEO Discusses Government Developments | John Wallington - CEO of Coal of Africa Ltd
00:10:00
Rochester Mine Expansion Set to Transform Coeur Mining's Free Cash Flow | Mitchell J. Krebs - President and CEO of Coeur Mining Inc

© 2017 - Neuhu+